Research workbench
Crystal structure of adhibin analogue-bound myosin-2
Analyse Crystal structure of adhibin analogue-bound myosin-2 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 6Z2S
- Type
- protein
- Length
- 748 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Myosin-2 heavy chain
- UniProt
- P08799
- Ligands
- Q5Q, AD9, MG
- Pockets
- 7 · best druggability 0.77
Structure
x-ray diffraction · 1 distinct chain · 44% helix, 16% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Myosin-2 heavy chain | protein | 748 | 44% helix, 16% strand | P08799 |
Ligands and binding sites
- Q5Q · 3,6-dibromo-1-(hydroxymethyl)carbazole · ligand · chains A
- AD9 · Adp metavanadate · ligand · chains A
- MG · Magnesium ion · metal · chains A
- GOL · Glycerol · additive · 5 copies · chains A
- ACT · Acetate ion · additive · 3 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 914 | 0.77 | 0.79 | 70 | Q5Q, GOL, ACT |
| 2 | 711 | 0.72 | 0.78 | 62 | empty |
| 3 | 477 | 0.67 | 0.79 | 54 | MG, AD9 |
| 4 | 89 | 0.46 | 0.81 | 23 | empty |
| 5 | 70 | 0.40 | 0.79 | 14 | empty |
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P08799
- Elsewhere: RCSB PDB 6Z2S · PDBe 6Z2S · UniProt P08799
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.